Incidence Status and Factors Associated With Tyrosine Kinase Inhibitor‐Induced Hypertension in Patients With Renal Cell Carcinoma
These findings indicate the importance of blood pressure management in patients with elevated baseline blood pressure.
Authors
- Shungo Imai (ORCID: https://orcid.org/0000-0001-5706-613X)
- Keisuke Ikegami (ORCID: https://orcid.org/0000-0002-6942-590X)
- Hayato Kizaki (ORCID: https://orcid.org/0000-0002-4572-1333)
- Satoko Hori (ORCID: https://orcid.org/0000-0002-4596-5418)
- Satoru Nakanishi (ORCID: https://orcid.org/0009-0002-7343-5104)
Institutions
- Keio University (JP)
Publication Details
- Journal
- Cancer Reports
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1002/cnr2.70219
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Science and Technology Agency
- Core Research for Evolutional Science and Technology